These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20730418)

  • 41. MDMA elicits behavioral and neurochemical sensitization in rats.
    Kalivas PW; Duffy P; White SR
    Neuropsychopharmacology; 1998 Jun; 18(6):469-79. PubMed ID: 9571655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
    O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors.
    Ramos L; Hicks C; Caminer A; Couto K; Narlawar R; Kassiou M; McGregor IS
    Pharmacol Biochem Behav; 2016; 150-151():115-123. PubMed ID: 27725273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity.
    Fone KC; Beckett SR; Topham IA; Swettenham J; Ball M; Maddocks L
    Psychopharmacology (Berl); 2002 Feb; 159(4):437-44. PubMed ID: 11823897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of MDMA and Intranasal oxytocin on social and emotional processing.
    Kirkpatrick MG; Lee R; Wardle MC; Jacob S; de Wit H
    Neuropsychopharmacology; 2014 Jun; 39(7):1654-63. PubMed ID: 24448644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
    Escobedo I; O'Shea E; Orio L; Sanchez V; Segura M; de la Torre R; Farre M; Green AR; Colado MI
    Br J Pharmacol; 2005 Jan; 144(2):231-41. PubMed ID: 15665862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine.
    Bullock TA; Berquist MD; Baker LE
    Behav Pharmacol; 2019 Oct; 30(7):566-573. PubMed ID: 31268871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
    J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring.
    Adori C; Zelena D; Tímár J; Gyarmati Z; Domokos A; Sobor M; Fürst Z; Makara G; Bagdy G
    Behav Brain Res; 2010 Jan; 206(2):299-309. PubMed ID: 19782105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats.
    Pedraza C; García FB; Navarro JF
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1165-77. PubMed ID: 19288974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
    Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice.
    Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Guerri C; Miñarro J
    Neurotoxicol Teratol; 2009; 31(1):49-59. PubMed ID: 18718862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.
    Ball KT; Wellman CL; Fortenberry E; Rebec GV
    Neuroscience; 2009 May; 160(2):264-74. PubMed ID: 19236907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
    Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects.
    Vizeli P; Liechti ME
    PLoS One; 2018; 13(6):e0199384. PubMed ID: 29912955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
    Nawata Y; Hiranita T; Yamamoto T
    Neuropsychopharmacology; 2010 Jan; 35(2):515-20. PubMed ID: 19829291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.